Nutraceuticals in the prevention and treatment of the muscle atrophy

52Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.

Abstract

Imbalance of protein homeostasis, with excessive protein degradation compared with protein synthesis, leads to the development of muscle atrophy resulting in a decrease in muscle mass and consequent muscle weakness and disability. Potential triggers of muscle atrophy include inflammation, malnutrition, aging, cancer, and an unhealthy lifestyle such as sedentariness and high fat diet. Nutraceuticals with preventive and therapeutic effects against muscle atrophy have recently received increasing attention since they are potentially more suitable for long-term use. The implementation of nutraceutical intervention might aid in the development and design of precision medicine strategies to reduce the burden of muscle atrophy. In this review, we will summarize the current knowledge on the importance of nutraceuticals in the prevention of skeletal muscle mass loss and recovery of muscle function. We also highlight the cellular and molecular mechanisms of these nutraceuticals and their possible pharmacological use, which is of great importance for the prevention and treatment of muscle atrophy.

Cite

CITATION STYLE

APA

Wang, Y., Liu, Q., Quan, H., Kang, S. G., Huang, K., & Tong, T. (2021, June 1). Nutraceuticals in the prevention and treatment of the muscle atrophy. Nutrients. MDPI AG. https://doi.org/10.3390/nu13061914

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free